Hemotune Secures CHF 14 Million for Clinical Trials

Hemotune obtient 14 millions de francs suisses pour ses essais cliniques

mar, 26 mars 2024

Hemotune’s innovative blood purification platform, HemoSystem, propels into clinical trials with a CHF 14 million Series B2 boost.

Hemotune AG, a Swiss biotech compmany, has concluded its Series B2 funding round, raising CHF 14 million, they claim in a press release. This pivotal financial injection, spearheaded by Belmondo and supported by stalwarts such as VP Venture Partners, heralds in the next stage of clinical trials for its groundbreaking HemoSystem blood purification platform.

The HemoSystem, uses nanoengineered magnetic beads. By eliminating large biomolecules directly from the bloodstream, it offers a novel avenue for multi-target treatments unattainable through conventional drug therapies.

Initially targeting the formidable challenge of sepsis-related immune suppression—a condition responsible for approximately 11 million fatalities annually and imposing a significant economic strain.

Lukas Langenegger, CEO and co-founder of Hemotune AG, expressed profound pride in the team’s milestone achievement of preclinical development and clinical trials.

Dr. Darius Madjdpour, the visionary founder at Belmondo, lauded Hemotune’s stellar performance over the past seven years, culminating in a platform technology with unparalleled potential in the medical field.

The HemoSystem’s capacity to address a spectrum of diseases and enable novel therapies was a key motivator for Belmondo’s lead role in this funding round.

Pascal Winnen, CEO of HEMEX, reaffirmed the CRO’s dedication to supporting Hemotune’s novel strategy to combat septic shock, recognising the technology’s vast potential to filter detrimental agents from the bloodstream selectively.

Articles connexes

Julius Baer Sells Kairos

3 mai 2024

Julius Baer finalizes the sale of Kairos to Anima Holding, removing the Italian "problem subsidiary" from its portfolio....

Federal Office of Police Cracks Down On Money Laundering

8 mai 2024

Switzerland's Federal Office of Police arrests key figures in a Europe-wide crackdown on money laundering activities...

Credit Suisse CEO To Step Down As UBS Merger Accelerates

6 mai 2024

UBS plans to dissolve Credit Suisse's management in the coming weeks, with CEO Ulrich Körner leaving post-merger,...

Geneva Will Not Remove Statues Of Colonialists & Racists

7 mai 2024

Geneva opts for dialogue and historical context over removing statues or renaming places associated with racism and...

Bern Riots: 11 Policeman Injured & Arrests

6 mai 2024

Unrest at Bern's Schützenmatte results in serious accusations by the regional police chief against rioters. ...

Brian Keller Pre-Trail Detention Approved In Zurich

6 mai 2024

Zurich court approves pre-trial detention for Brian Keller, citing "risk of repetition." The 28-year-old faces charges...

Sandoz Q1 Strong Start To The Year With Biosimilars Growth

7 mai 2024

Sandoz sees a solid financial start in 2024, with biosimilars growing 21%, contributing to a total revenue of $2.5...

Rester en contact

À noter

Two Men In Court After They Posted Viral Videos Driving 250 km/h

À noter

25 avril 2024

Deux hommes comparaissent devant un tribunal après avoir posté des vidéos virales dans lesquelles ils roulaient à 250 km/h

À noter

30 avril 2024

Hemotune obtient 14 millions de francs suisses pour ses essais cliniques

Hemotune obtient 14 millions de francs suisses pour ses essais cliniques

Articles connexes

Rester en contact

À noter

Deux hommes comparaissent devant un tribunal après avoir posté des vidéos virales dans lesquelles ils roulaient à 250 km/h

Le marché du travail suisse est touché au premier trimestre

Liens rapides